Julie K. Geyer

This study identifies PRAME as a therapeutic target in NUT carcinoma, showing its high expression and susceptibility to T-cell mediated cytotoxicity via PRAME epitopes presented by HLA Class I molecules.

This study demonstrates real-time genomic classification of pediatric acute leukemia using long-read sequencing with adaptive sampling, identifying key alterations faster than traditional methods.